ImmuDyne's Skin Cream Patent Win Partly Reversed

Law360, New York (June 19, 2009, 12:00 AM EDT) -- A Texas appeals court has largely upheld a ruling in favor of ImmuDyne Inc. in a patent dispute with Biopolymer Engineering Inc. over yeast-based skin treatments, but reversed it with regard to two of the seven patents-at-issue.

The Court of Appeals of Texas, Fourth District, on Wednesday rejected most of an appeal by Biopolymer, which had argued that ImmuDyne had not properly acquired ownership and licenses for the patents. The court upheld a jury verdict in ImmuDyne's favor on most of the patents, but found that...
To view the full article, register now.